These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 8169754)

  • 1. Treatment and prevention options for respiratory syncytial virus infections.
    Levin MJ
    J Pediatr; 1994 May; 124(5 Pt 2):S22-7. PubMed ID: 8169754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis.
    Groothuis JR; Hoopes JM; Hemming VG
    Adv Ther; 2011 Feb; 28(2):110-25. PubMed ID: 21318605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment and prevention of respiratory syncytial virus infection.
    Kneyber MC; Moll HA; de Groot R
    Eur J Pediatr; 2000 Jun; 159(6):399-411. PubMed ID: 10867843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of respiratory syncytial virus immune globulin in 1996-1997: a local controlled comparison.
    Redding GJ; Braun S; Mayock D
    Arch Pediatr Adolesc Med; 1999 May; 153(5):503-7. PubMed ID: 10323631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.
    Rodriguez WJ; Gruber WC; Welliver RC; Groothuis JR; Simoes EA; Meissner HC; Hemming VG; Hall CB; Lepow ML; Rosas AJ; Robertsen C; Kramer AA
    Pediatrics; 1997 Mar; 99(3):454-61. PubMed ID: 9041304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention strategies for respiratory syncytial virus: passive and active immunization.
    Englund JA
    J Pediatr; 1999 Aug; 135(2 Pt 2):38-44. PubMed ID: 10431138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group.
    Groothuis JR; Simoes EA; Levin MJ; Hall CB; Long CE; Rodriguez WJ; Arrobio J; Meissner HC; Fulton DR; Welliver RC
    N Engl J Med; 1993 Nov; 329(21):1524-30. PubMed ID: 8413475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group.
    Groothuis JR; Simoes EA; Hemming VG
    Pediatrics; 1995 Apr; 95(4):463-7. PubMed ID: 7700741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy for respiratory tract infections caused by respiratory syncytial virus.
    van Woensel J; Kimpen J
    Eur J Pediatr; 2000 Jun; 159(6):391-8. PubMed ID: 10867842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Historical Perspective on Respiratory Syncytial Virus Prevention: A Journey Spanning Over Half a Century From the Setback of an Inactive Vaccine Candidate to the Success of Passive Immunization Strategy.
    Noor A; Krilov LR
    J Pediatric Infect Dis Soc; 2024 Jul; 13(Supplement_2):S103-S109. PubMed ID: 38577737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compassionate use experience with high-titer respiratory syncytical virus (RSV) immunoglobulin in RSV-infected immunocompromised persons.
    Falsey AR; Koval C; DeVincenzo JP; Walsh EE
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28054734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory syncytial virus disease: update on treatment and prevention.
    Krilov LR
    Expert Rev Anti Infect Ther; 2011 Jan; 9(1):27-32. PubMed ID: 21171875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory syncytial virus (RSV) disease and prospects for its control.
    Wyde PR
    Antiviral Res; 1998 Aug; 39(2):63-79. PubMed ID: 9806484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current respiratory syncytial virus prevention strategies in high-risk infants.
    Weisman LE
    Pediatr Int; 2002 Oct; 44(5):475-80. PubMed ID: 12225544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive protection against respiratory syncytial virus disease in infants: the role of maternal antibody.
    Englund JA
    Pediatr Infect Dis J; 1994 May; 13(5):449-53. PubMed ID: 8072835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and treatment recommendations for respiratory syncytial virus infection. Background and clinical experience 40 years after discovery.
    Ottolini MG; Hemming VG
    Drugs; 1997 Dec; 54(6):867-84. PubMed ID: 9421694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [-Prevention of respiratory syncytial virus infection-].
    Gillet Y
    Arch Pediatr; 1998 Mar; 5(3):333-7. PubMed ID: 10328005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.
    Hemming VG; Prince GA; Groothuis JR; Siber GR
    Clin Microbiol Rev; 1995 Jan; 8(1):22-33. PubMed ID: 7704893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory syncytial virus infection in children with congenital heart disease: a review.
    Fixler DE
    Pediatr Cardiol; 1996; 17(3):163-8. PubMed ID: 8662029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy?
    Munoz FM
    Curr Opin Infect Dis; 2015 Jun; 28(3):221-4. PubMed ID: 25918956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.